Skip to main content
Erschienen in: Surgical Endoscopy 12/2007

01.12.2007 | Review

Deep venous thrombosis prophylaxis in laparoscopy: An evidence-based review

verfasst von: William S. Richardson, Keith Apelgren, Robert D. Fanelli, David Earle

Erschienen in: Surgical Endoscopy | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Excerpt

There is considerable controversy over the best practice for the prevention of venous thromboembolic (VTE) disease during laparoscopic surgery. When considering prophylactic therapy for any disease, the risk–benefit ratio of the therapy and the disease should be considered, as well as the cost effectiveness and ability to employ the prophylactic strategy effectively across the health care system as a whole. This evidence-based review will examine the strategy of risk stratification when employing prophylactic therapy for VTE disease patients undergoing laparoscopic procedures. Although there are examples of specific procedures, the basic philosophy is that the prophylactic therapy should be tailored to the needs of the individual patient based on estimated risk of VTE disease. Therefore there may be a specific procedure that has a variety of treatment strategies for varying clinical scenarios. …
Literatur
1.
Zurück zum Zitat Haas S, Flosbach CW (1993) Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemost 19 suppl 1:164–173PubMed Haas S, Flosbach CW (1993) Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemost 19 suppl 1:164–173PubMed
2.
Zurück zum Zitat Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman E, Wolfe BM (2001) Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 136(8):909–916CrossRefPubMed Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman E, Wolfe BM (2001) Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 136(8):909–916CrossRefPubMed
3.
Zurück zum Zitat Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, Clements RH (2004) Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 18(7):1082–1084CrossRefPubMed Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, Clements RH (2004) Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 18(7):1082–1084CrossRefPubMed
4.
Zurück zum Zitat Millard JA, Hill BB, Cook PS, Fenoglio ME, Stahlgren LH (1993) Intermittent sequential pneumatic compression in prevention of venous stasis associated with pneumoperitoneum during laparoscopic cholecystectomy. Arch Surg 128(8):914–918; discussion 918–919PubMed Millard JA, Hill BB, Cook PS, Fenoglio ME, Stahlgren LH (1993) Intermittent sequential pneumatic compression in prevention of venous stasis associated with pneumoperitoneum during laparoscopic cholecystectomy. Arch Surg 128(8):914–918; discussion 918–919PubMed
5.
Zurück zum Zitat Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160(22):3415–3420CrossRefPubMed Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160(22):3415–3420CrossRefPubMed
6.
Zurück zum Zitat Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ (2002) 3rd Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162(11):1245–1248CrossRefPubMed Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ (2002) 3rd Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162(11):1245–1248CrossRefPubMed
7.
Zurück zum Zitat Blaszyk H, Bjornsson J. Factor V (2000) leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg 135(12):1410–1413CrossRefPubMed Blaszyk H, Bjornsson J. Factor V (2000) leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg 135(12):1410–1413CrossRefPubMed
8.
Zurück zum Zitat Haas S, Flosbach CW (1993) Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemos 19 suppl 1:164–173 Haas S, Flosbach CW (1993) Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemos 19 suppl 1:164–173
9.
Zurück zum Zitat Nurmohamed MT, Verhaeghe R, Haas S, Iriarte JA, Vogel G, van Rij AM, Prentice CR, ten Cate JW (1995) A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 169(6):567–571CrossRefPubMed Nurmohamed MT, Verhaeghe R, Haas S, Iriarte JA, Vogel G, van Rij AM, Prentice CR, ten Cate JW (1995) A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 169(6):567–571CrossRefPubMed
10.
Zurück zum Zitat Anderson DR, O’Brien BJ (1997) Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism. Pharmacoeconomics 12(1):17–29CrossRefPubMed Anderson DR, O’Brien BJ (1997) Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism. Pharmacoeconomics 12(1):17–29CrossRefPubMed
11.
Zurück zum Zitat Avikainen V, von Bonsdorff H, Partio E, Kaira P, Hakkinen S, Usenius JP, Kaaja R (1995) Low molecular weight heparin (Enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement. Annales chirurgiae et gynaecologiae 84:85–90PubMed Avikainen V, von Bonsdorff H, Partio E, Kaira P, Hakkinen S, Usenius JP, Kaaja R (1995) Low molecular weight heparin (Enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement. Annales chirurgiae et gynaecologiae 84:85–90PubMed
12.
Zurück zum Zitat Clagett GP, Reisch JS (1988) Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 208(2):227–240CrossRefPubMed Clagett GP, Reisch JS (1988) Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 208(2):227–240CrossRefPubMed
13.
Zurück zum Zitat Colditz GA, Tuden RL, Oster G (1986) Rates of venous thrombosis after general surgery: combined results of randomized clinical trials. Lancet 19:143–146CrossRef Colditz GA, Tuden RL, Oster G (1986) Rates of venous thrombosis after general surgery: combined results of randomized clinical trials. Lancet 19:143–146CrossRef
14.
Zurück zum Zitat Miller MT, Rovito PF (2004) An approach to venous thromboembolism prophylaxis in laparoscopic roux-en-Y gastric bypass surgery. Obes Surg 14(6):731–737CrossRefPubMed Miller MT, Rovito PF (2004) An approach to venous thromboembolism prophylaxis in laparoscopic roux-en-Y gastric bypass surgery. Obes Surg 14(6):731–737CrossRefPubMed
15.
Zurück zum Zitat Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity. Obes Sur. 13(6):819–825CrossRef Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity. Obes Sur. 13(6):819–825CrossRef
16.
Zurück zum Zitat Dunn CJ, Goa K (1996) Enoxaparin a pharmacoenconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty. Pharmacoeconomics 10(2):179–190CrossRefPubMed Dunn CJ, Goa K (1996) Enoxaparin a pharmacoenconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty. Pharmacoeconomics 10(2):179–190CrossRefPubMed
17.
Zurück zum Zitat Leali A, Fetto J, Moroz A (2002) Prevention of thromboembolic disease after non-cemented hip arthroplasty. A multimodal approach. Acta Orthop Belg 68(2):128–134PubMed Leali A, Fetto J, Moroz A (2002) Prevention of thromboembolic disease after non-cemented hip arthroplasty. A multimodal approach. Acta Orthop Belg 68(2):128–134PubMed
18.
Zurück zum Zitat Douketis JD, Kinnon K, Crowther MA (2002) Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily low molecular-weight heparin and continuous epidural analgesia after orthopedic surgery. Thromb Haemost 88(1):37–40PubMed Douketis JD, Kinnon K, Crowther MA (2002) Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily low molecular-weight heparin and continuous epidural analgesia after orthopedic surgery. Thromb Haemost 88(1):37–40PubMed
19.
Zurück zum Zitat Geerts WH, Pineo GF, Heit JA, Bergquist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):338s–400sCrossRefPubMed Geerts WH, Pineo GF, Heit JA, Bergquist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):338s–400sCrossRefPubMed
20.
Zurück zum Zitat Kalve SP, Athanasoulis CA, Fan CM, Curvelo M, Geller SC, Greenfield AJ, Waltman AC, Wicky S (2006) “Recovery trade mark” vena cava filter: experience in 96 patients. Cardiovasc Intervent Radiol (epub ahead of print) Kalve SP, Athanasoulis CA, Fan CM, Curvelo M, Geller SC, Greenfield AJ, Waltman AC, Wicky S (2006) “Recovery trade mark” vena cava filter: experience in 96 patients. Cardiovasc Intervent Radiol (epub ahead of print)
21.
Zurück zum Zitat Scholten DJ, Hoedema RM, Scholten SE (2002) A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12:19–24CrossRefPubMed Scholten DJ, Hoedema RM, Scholten SE (2002) A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12:19–24CrossRefPubMed
22.
Zurück zum Zitat Warkentin TE (2006) Hematology. Am Soc Hematol Educ Program 408–414 Warkentin TE (2006) Hematology. Am Soc Hematol Educ Program 408–414
Metadaten
Titel
Deep venous thrombosis prophylaxis in laparoscopy: An evidence-based review
verfasst von
William S. Richardson
Keith Apelgren
Robert D. Fanelli
David Earle
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 12/2007
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-007-9544-x

Weitere Artikel der Ausgabe 12/2007

Surgical Endoscopy 12/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.